about
Metabolic syndrome and renal cell carcinomaDiagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese populationEfficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: results from a multicenter studyPrognostic significance of the degree of extranodal extension in patients with penile carcinoma.Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes.External validation of nomograms for predicting cancer-specific mortality in penile cancer patients treated with definitive surgery.Polymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations.Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapseComplicated variation of simple renal cyst usually means malignancy: results from a cohort studyGenitourinary small-cell carcinoma: 11-year treatment experience.Clinical outcome of advanced and metastatic renal cell carcinoma treated with targeted therapy: is there a difference between young and old patients?Genetic variations of the ADIPOQgene and risk of prostate cancer in Chinese Han men.Constitutively active AR-V7 plays an essential role in the development and progression of castration-resistant prostate cancer.Prostate cancer in East Asia: evolving trend over the last decade.Prognostic value of components of body composition in patients treated with targeted therapy for advanced renal cell carcinoma: a retrospective case seriesPathological features of localized prostate cancer in China: a contemporary analysis of radical prostatectomy specimensMicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer.ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma.Surgical treatment of primary disease for penile squamous cell carcinoma: A Surveillance, Epidemiology, and End Results database analysisUse of RENAL nephrometry scores for predicting tumor upgrading between core biopsies and surgical specimens: a prospective ex vivo study.Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinomaThe association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomyDevelopment and external validation of a prostate health index-based nomogram for predicting prostate cancer.Pretreatment Neutrophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiving Radical Prostatectomy.Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk: A Cross-Sectional Analysis in China.Prognostic significance of the TREK-1 K2P potassium channels in prostate cancerSerum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy.Abnormal methylation status of FBXW10 and SMPD3, and associations with clinical characteristics in clear cell renal cell carcinoma.Influence of age on predictiveness of genetic risk score for prostate cancer in a Chinese hospital-based biopsy cohort.Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patientsEffect of body mass index on the performance characteristics of PSA-related markers to detect prostate cancer.Predicting the failure of retrograde ureteral stent insertion for managing malignant ureteral obstruction in outpatients.A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer.Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy.Assessment of survival of patients with metastatic clear cell renal cell carcinoma after radical cytoreductive nephrectomy versus no surgery: a seer analysis.Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma.External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort.Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonographyA novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib
P50
Q26825147-89F1593F-8436-4579-A2E1-7B86ACCC750AQ31046172-B702DFD2-B1B8-4163-B9FC-DFAF359BC5A6Q33485003-FA317ED9-320C-43B0-9269-A27DDBB06797Q33621433-D5CCF500-32F3-4031-A5F4-F910DCCFB6D9Q33629791-5DF8EBF4-E5E1-41CD-B062-E592FFF91986Q33633273-2AD90BD9-3789-4A12-9B49-EC18E0953B11Q33648490-AC1316DA-691E-4513-BC46-B37D30411849Q33668676-469DB9F0-305E-4BAF-B2BB-A6FBAE110884Q34363094-A58E6A32-5CEC-4EEE-BBA7-FE83110C78B3Q34433238-9E27D55E-53CD-4465-98E6-AADF0B72C75CQ34471312-6BF065C5-4BC0-4B78-8922-6D80825CE9A9Q34536858-ECFBCF46-C916-48BF-B239-1182577DCC62Q34883636-2F839840-6BFC-4F36-BE3B-5486646A14ECQ34927940-075A461C-00FB-46E2-92E2-0B56D3035F0CQ35068826-FC7E446B-5A58-4AFF-8449-9876C5DBF80AQ35208324-0ECE6414-702A-422E-BC1D-0353F28B836BQ35617323-8A5416EE-F663-434F-BEB1-286B85BCD69CQ35754260-B9CDC763-87FD-45E9-9ACF-9DC1F684618AQ35803475-F41BA93A-0782-4495-BBAB-181F263576A6Q36009458-0EFB4551-E392-4AE2-96D9-4B6480BCB76BQ36074171-6F6C48DC-D4CC-4C9A-A7F9-11F658464A7AQ36080375-73C050BB-5BC0-46E4-95FB-F8219805B292Q36168333-BF890B97-DF0E-40AA-A12B-C127EB884AA4Q36195647-FF8424AE-227A-41FD-803F-3232682174EFQ36206929-F6DAD36C-A670-4472-AB76-DF945660C489Q36210906-E0426F9D-9DB4-4FBB-ACFC-6170A0914342Q36293122-7659D498-220E-4B90-A3B2-2F4E12B00B6EQ36334886-94820C16-C78E-4C1F-B88C-3D830643F2E1Q36356134-F5DDDA85-32E7-4E2C-A813-E5EB12D1E96CQ36413776-859E29CD-5C0A-4922-9B8E-7DF6BDD0F513Q36453223-946A773F-7A08-4541-A5A1-970761E5A471Q36502664-B859363B-A8B0-4E9E-BC7A-E8F982762F0FQ36544815-FF0C28DA-6DC9-481A-A347-EEF3F1F58302Q36544819-B373AF95-4977-4192-9AEC-59EB261A2646Q36575806-A5A7D6D9-F146-496E-8417-6D981E946607Q36741509-11CC09FA-3C5B-425D-945F-57078C72D628Q37074118-03523906-0DAE-47A0-8F5E-042A767A076BQ37113204-CFA5C0B6-4145-4AB1-8FCF-63E5873A249EQ37127412-08307FF1-CD8C-4209-89E4-78EBEF4E09C2Q37295831-BF8B0FEE-62FB-4E0D-B808-437EE75F5D1B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Yao Zhu
@en
Yao Zhu
@nl
type
label
Yao Zhu
@en
Yao Zhu
@nl
prefLabel
Yao Zhu
@en
Yao Zhu
@nl
P31
P496
0000-0001-7950-6669